Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif.

Molecular cell | Mar 28, 1998

http://www.ncbi.nlm.nih.gov/pubmed/9660940

HIV-1 Vpu interacts with CD4 in the endoplasmic reticulum and triggers CD4 degradation, presumably by proteasomes. Human beta TrCP identified by interaction with Vpu connects CD4 to this proteolytic machinery, and CD4-Vpu-beta TrCP ternary complexes have been detected by coimmunoprecipitation. beta TrCP binding to Vpu and its recruitment to membranes require two phosphoserine residues in Vpu essential for CD4 degradation. In beta TrCP, WD repeats at the C terminus mediate binding to Vpu, and an F box near the N terminus is involved in interaction with Skp1p, a targeting factor for ubiquitin-mediated proteolysis. An F-box deletion mutant of beta TrCP had a dominant-negative effect on Vpu-mediated CD4 degradation. These data suggest that beta TrCP and Skp1p represent components of a novel ER-associated protein degradation pathway that mediates CD4 proteolysis.

Pubmed ID: 9660940 RIS Download

Mesh terms: Antigens, CD4 | Binding Sites | Cell Cycle Proteins | Endoplasmic Reticulum | GTP-Binding Proteins | HIV-1 | Human Immunodeficiency Virus Proteins | Humans | Jurkat Cells | Molecular Sequence Data | Mutagenesis | Repetitive Sequences, Nucleic Acid | S-Phase Kinase-Associated Proteins | Sequence Homology, Amino Acid | Serine | Ubiquitins | Viral Regulatory and Accessory Proteins | beta-Transducin Repeat-Containing Proteins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.